highly significantp-value = 0.034
Figure 7B represents one dataset analyzed in Figure 7A , the vandeVijver breast carcinoma study, and shows that BRF2 overexpression is highly significant in patients presenting with metastasis at year 1, p-value = 0.034, and at year 5, p-value = 0.006.